Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Red Violet | RDVT | Aug 30, 2024 | 28.90 | -1.73 |
RDDT | Aug 30, 2024 | 60.03 | +2.18 | |
Redfin | RDFN | Aug 30, 2024 | 9.34 | -1.58 |
RedHill Biopharma ADR | RDHL | Aug 30, 2024 | 8.50 | -1.39 |
Redwire | RDW | Aug 30, 2024 | 6.75 | +1.20 |
Redwood Trust | RWT-A | Aug 30, 2024 | 25.19 | +0.14 |
Redwood Trust | RWT | Aug 30, 2024 | 7.57 | +0.80 |
REE Automotive A | REE | Aug 30, 2024 | 3.68 | -1.12 |
Regal Rexnord | RRX | Aug 30, 2024 | 167.81 | +1.56 |
Regency Centers | REG | Aug 30, 2024 | 72.69 | +1.42 |
Regency Centers A Pref | REGCP | Aug 30, 2024 | 23.73 | -1.13 |
Regency Centers B Pref | REGCO | Aug 30, 2024 | 22.94 | +0.39 |
Regeneron Pharmaceuticals | REGN | Aug 30, 2024 | 1 184.69 | +0.49 |
REGENXBIO | RGNX | Aug 30, 2024 | 12.22 | +1.83 |
Regional Health Properties | RHE | Aug 30, 2024 | 1.86 | -2.88 |
Regional Health Properties A Pref | RHE-A | Aug 30, 2024 | 0.46 | 0.00 |
Regional Management | RM | Aug 30, 2024 | 33.53 | +0.57 |
Regions Financial | RF | Aug 30, 2024 | 23.42 | +0.90 |
Regions Financial B Pref | RF-B | Aug 30, 2024 | 25.36 | +0.16 |
Regions Financial C Pref | RF-C | Aug 30, 2024 | 23.78 | -1.78 |
Regions Financial E Pref | RF-E | Aug 30, 2024 | 18.53 | -1.91 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Aug 30, 2024 | 25.48 | 0.00 |
Regis | RGS | Aug 30, 2024 | 21.00 | -7.89 |
Regulus Therapeutics | RGLS | Aug 30, 2024 | 1.68 | +1.82 |
Reinsurance Group of America | RGA | Aug 30, 2024 | 220.76 | +1.65 |
REIT Index ETF Vanguard | VNQ | Aug 30, 2024 | 95.13 | +0.97 |
Rekor Systems | REKR | Aug 30, 2024 | 1.25 | +0.81 |
Relay Therapeutics | RLAY | Aug 30, 2024 | 6.79 | +0.44 |
Reliance | RS | Aug 30, 2024 | 286.65 | +2.16 |
Reliance Global | RELI | Aug 30, 2024 | 2.80 | -0.36 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.